Cargando…
Novel quinazolinone MJ-33 induces AKT/mTOR-mediated autophagy-associated apoptosis in 5FU-resistant colorectal cancer cells
Novel quinazolinone compounds have been studied in the field of drug discovery for a long time. Among their broad range of pharmacological effects, certain compounds effectively inhibit cancer cell proliferation. MJ-33 is a quinazolinone derivative with proposed anticancer activities that was synthe...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757098/ https://www.ncbi.nlm.nih.gov/pubmed/33416156 http://dx.doi.org/10.3892/or.2020.7882 |
_version_ | 1783626677111226368 |
---|---|
author | Ha, Hai-Anh Chiang, Jo-Hua Tsai, Fuu-Jen Bau, Da-Tian Juan, Yu-Ning Lo, Yu-Hsiang Hour, Mann-Jen Yang, Jai-Sing |
author_facet | Ha, Hai-Anh Chiang, Jo-Hua Tsai, Fuu-Jen Bau, Da-Tian Juan, Yu-Ning Lo, Yu-Hsiang Hour, Mann-Jen Yang, Jai-Sing |
author_sort | Ha, Hai-Anh |
collection | PubMed |
description | Novel quinazolinone compounds have been studied in the field of drug discovery for a long time. Among their broad range of pharmacological effects, certain compounds effectively inhibit cancer cell proliferation. MJ-33 is a quinazolinone derivative with proposed anticancer activities that was synthesized in our laboratory. The present study aimed to evaluate the anticancer activity of MJ-33 in fluorouracil (5FU)-resistant colorectal cancer cells (HT-29/5FUR) and to investigate the underlying molecular mechanisms. The cell viability assay results indicated that HT-29/5FUR cell viability was inhibited by MJ-33 treatment in a concentration-dependent manner compared with the control group. The cellular morphological alterations observed following MJ-33 treatment indicated the occurrence of apoptosis and autophagy, as well as inhibition of cell proliferation in a time-dependent manner compared with the control group. The acridine orange, LysoTracker Red and LC3-green fluorescent protein staining results indicated that MJ-33 treatment significantly induced autophagy compared with the control group. The DAPI/TUNEL dual staining results demonstrated increased nuclear fragmentation and condensation following MJ-33 treatment compared with the control group. The Annexin V apoptosis assay and image cytometry analysis results demonstrated a significant increase in apoptotic cells following MJ-33 treatment compared with the control group. The western blotting results demonstrated markedly decreased Bcl-2, phosphorylated (p)-BAD, pro-caspase-9 and pro-caspase-3 expression levels, and notably increased cytochrome c and apoptotic peptidase activating factor 1 expression levels following MJ-33 treatment compared with the control group. Moreover, the expression levels of autophagy-related proteins, including autophagy related (ATG)-5, ATG-7, ATG-12, ATG-16, p62 and LC3-II, were increased following MJ-33 treatment compared with the control group. Furthermore, MJ-33-treated HT-29/5FUR cells displayed decreased expression levels of p-AKT and p-mTOR compared with control cells. The results suggested that MJ-33-induced apoptosis was mediated by AKT signaling, and subsequently modulated via the mitochondria-dependent signaling pathway. Therefore, the results suggested that suppression of AKT/mTOR activity triggered autophagy in the HT-29/5FUR cell line. In summary, the results indicated that MJ-33 inhibited HT-29/5FUR cell viability, and induced apoptosis and autophagy via the AKT/mTOR signaling pathway. The present study may provide novel insight into the anticancer effects and mechanisms underlying MJ-33 in 5FU-resistant colorectal cancer cells. |
format | Online Article Text |
id | pubmed-7757098 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-77570982020-12-31 Novel quinazolinone MJ-33 induces AKT/mTOR-mediated autophagy-associated apoptosis in 5FU-resistant colorectal cancer cells Ha, Hai-Anh Chiang, Jo-Hua Tsai, Fuu-Jen Bau, Da-Tian Juan, Yu-Ning Lo, Yu-Hsiang Hour, Mann-Jen Yang, Jai-Sing Oncol Rep Articles Novel quinazolinone compounds have been studied in the field of drug discovery for a long time. Among their broad range of pharmacological effects, certain compounds effectively inhibit cancer cell proliferation. MJ-33 is a quinazolinone derivative with proposed anticancer activities that was synthesized in our laboratory. The present study aimed to evaluate the anticancer activity of MJ-33 in fluorouracil (5FU)-resistant colorectal cancer cells (HT-29/5FUR) and to investigate the underlying molecular mechanisms. The cell viability assay results indicated that HT-29/5FUR cell viability was inhibited by MJ-33 treatment in a concentration-dependent manner compared with the control group. The cellular morphological alterations observed following MJ-33 treatment indicated the occurrence of apoptosis and autophagy, as well as inhibition of cell proliferation in a time-dependent manner compared with the control group. The acridine orange, LysoTracker Red and LC3-green fluorescent protein staining results indicated that MJ-33 treatment significantly induced autophagy compared with the control group. The DAPI/TUNEL dual staining results demonstrated increased nuclear fragmentation and condensation following MJ-33 treatment compared with the control group. The Annexin V apoptosis assay and image cytometry analysis results demonstrated a significant increase in apoptotic cells following MJ-33 treatment compared with the control group. The western blotting results demonstrated markedly decreased Bcl-2, phosphorylated (p)-BAD, pro-caspase-9 and pro-caspase-3 expression levels, and notably increased cytochrome c and apoptotic peptidase activating factor 1 expression levels following MJ-33 treatment compared with the control group. Moreover, the expression levels of autophagy-related proteins, including autophagy related (ATG)-5, ATG-7, ATG-12, ATG-16, p62 and LC3-II, were increased following MJ-33 treatment compared with the control group. Furthermore, MJ-33-treated HT-29/5FUR cells displayed decreased expression levels of p-AKT and p-mTOR compared with control cells. The results suggested that MJ-33-induced apoptosis was mediated by AKT signaling, and subsequently modulated via the mitochondria-dependent signaling pathway. Therefore, the results suggested that suppression of AKT/mTOR activity triggered autophagy in the HT-29/5FUR cell line. In summary, the results indicated that MJ-33 inhibited HT-29/5FUR cell viability, and induced apoptosis and autophagy via the AKT/mTOR signaling pathway. The present study may provide novel insight into the anticancer effects and mechanisms underlying MJ-33 in 5FU-resistant colorectal cancer cells. D.A. Spandidos 2021-02 2020-12-03 /pmc/articles/PMC7757098/ /pubmed/33416156 http://dx.doi.org/10.3892/or.2020.7882 Text en Copyright: © Ha et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Ha, Hai-Anh Chiang, Jo-Hua Tsai, Fuu-Jen Bau, Da-Tian Juan, Yu-Ning Lo, Yu-Hsiang Hour, Mann-Jen Yang, Jai-Sing Novel quinazolinone MJ-33 induces AKT/mTOR-mediated autophagy-associated apoptosis in 5FU-resistant colorectal cancer cells |
title | Novel quinazolinone MJ-33 induces AKT/mTOR-mediated autophagy-associated apoptosis in 5FU-resistant colorectal cancer cells |
title_full | Novel quinazolinone MJ-33 induces AKT/mTOR-mediated autophagy-associated apoptosis in 5FU-resistant colorectal cancer cells |
title_fullStr | Novel quinazolinone MJ-33 induces AKT/mTOR-mediated autophagy-associated apoptosis in 5FU-resistant colorectal cancer cells |
title_full_unstemmed | Novel quinazolinone MJ-33 induces AKT/mTOR-mediated autophagy-associated apoptosis in 5FU-resistant colorectal cancer cells |
title_short | Novel quinazolinone MJ-33 induces AKT/mTOR-mediated autophagy-associated apoptosis in 5FU-resistant colorectal cancer cells |
title_sort | novel quinazolinone mj-33 induces akt/mtor-mediated autophagy-associated apoptosis in 5fu-resistant colorectal cancer cells |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757098/ https://www.ncbi.nlm.nih.gov/pubmed/33416156 http://dx.doi.org/10.3892/or.2020.7882 |
work_keys_str_mv | AT hahaianh novelquinazolinonemj33inducesaktmtormediatedautophagyassociatedapoptosisin5furesistantcolorectalcancercells AT chiangjohua novelquinazolinonemj33inducesaktmtormediatedautophagyassociatedapoptosisin5furesistantcolorectalcancercells AT tsaifuujen novelquinazolinonemj33inducesaktmtormediatedautophagyassociatedapoptosisin5furesistantcolorectalcancercells AT baudatian novelquinazolinonemj33inducesaktmtormediatedautophagyassociatedapoptosisin5furesistantcolorectalcancercells AT juanyuning novelquinazolinonemj33inducesaktmtormediatedautophagyassociatedapoptosisin5furesistantcolorectalcancercells AT loyuhsiang novelquinazolinonemj33inducesaktmtormediatedautophagyassociatedapoptosisin5furesistantcolorectalcancercells AT hourmannjen novelquinazolinonemj33inducesaktmtormediatedautophagyassociatedapoptosisin5furesistantcolorectalcancercells AT yangjaising novelquinazolinonemj33inducesaktmtormediatedautophagyassociatedapoptosisin5furesistantcolorectalcancercells |